Great article: Summary/Conclusion: Our results
Post# of 72440
Summary/Conclusion:
Our results show kevetrin alters several key genes and cellular metabolism. Along with cellular data, this study could provide a rationale for an experimental trial in AML patients, especially those carrying TP53 mutation who actually have very few therapeutic options.